Literature DB >> 948760

Monoamine changes in the brain of cats during slow-wave sleep.

R Kovacević, M Radulovacki.   

Abstract

We have found that the metabolism of 5-hydroxytryptamine increases in the hippocampus and that the metabolism of dopamine decreases in the striatum and thalamus during slow-wave sleep, and we suggest that these changes are related to this stage of sleep. We have also found that the concentration of dopamine increases in the hippocampus during slow-wave sleep, and suggest that this may be related to the subsequent appearance of paradoxical sleep. These data raise new questions on the hippocampal role in the sleep-wakefulness cycle.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 948760     DOI: 10.1126/science.948760

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan.

Authors:  C Idzikowski; P J Cowen; D Nutt; F J Mills
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  The organization and regulation of sleep. A review of the experimental evidence and a novel integrated model of the organizing and regulating apparatus.

Authors:  W P Koella
Journal:  Experientia       Date:  1984-04-15

3.  A modern neurobiological concept of vigilance.

Authors:  W P Koella
Journal:  Experientia       Date:  1982-12-15

4.  Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material.

Authors:  K Jellinger; P Riederer
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 5.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

6.  Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.

Authors:  Z Lelkes; F Obál; G Benedek; G Rubicsek; P Alföldi; F Obál
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.